Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. The firm owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. The company also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. The company also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Mr. Grigorios Siokas est le Chairman of the Board de Cosmos Health Inc, il a rejoint l'entreprise depuis 2016.
Quelle est la performance du prix de l'action COSM ?
Le prix actuel de COSM est de $0.344, il a diminué de 0.08% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Cosmos Health Inc ?
Cosmos Health Inc appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Cosmos Health Inc ?
La capitalisation boursière actuelle de Cosmos Health Inc est de $12.0M
Est-ce que Cosmos Health Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 3 analystes ont établi des notations d'analystes pour Cosmos Health Inc, y compris 2 achat fort, 4 achat, 1 maintien, 0 vente et 2 vente forte